Displaying 1 to 14 of 14 investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | N/A Active |
|
|
|
CoMentis Inc |
United States | N/A |
|
|
|
DecImmune Therapeutics Inc Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction |
United States | N/A |
|
|
|
Epizyme Inc Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). |
United States | N/A |
|
|
|
Evolva Holding SA |
Switzerland | N/A |
|
|
|
F2G Ltd |
United Kingdom | N/A |
|
|
Fate Therapeutics Inc |
United States | N/A |
|
|
|
Inimex Pharmaceuticals Inc |
Canada | N/A |
|
|
|
Lectus Therapeutics Ltd |
United Kingdom | N/A |
|
|
|
Nereus Pharmaceuticals Inc |
United States | N/A |
|
|
|
PhaseBio Pharmaceuticals Inc |
United States | N/A |
|
|
|
TaiGen Biotechnology Co Ltd Pharmaceutical company engaging in the development of novel therapeutics. |
United States | N/A |
|
|
|
Verastem Inc |
United States | N/A |
|
|
|
Viamet Pharmaceuticals Inc |
United States | N/A |